CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.
about
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpartThe spectrum of cognitive impairment in Lewy body diseasesAltered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia.Neurobiology of cognitive impairment in Parkinson's disease.Catecholamine-Based Treatment in AD Patients: Expectations and Delusions.FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
P2860
Q33921178-AA24C47C-151E-432C-BCFD-AB0B15D1A23CQ34019751-43305589-4590-4F7C-BA2D-87FE28B23DD6Q34760606-3B985775-9EAA-4717-93A0-152C49956B3DQ36933691-729426B1-20B1-4906-A317-FCC1BAA18902Q38067143-6493DF81-1F88-47D0-879F-366A348B8A3DQ38497202-1E66E9D7-5C0C-4842-B1E3-6DBFA4BE9F45Q47553874-F098D657-94A4-433C-BF18-1A95C12D82C5
P2860
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.
@en
type
label
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.
@en
prefLabel
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.
@en
P2860
P50
P1476
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD
@en
P2093
Livia Brusa
Mariangela Pierantozzi
P2860
P2888
P304
P356
10.1007/S00702-012-0820-0
P577
2012-05-24T00:00:00Z